Last10K.com

Diamond Information Institute (TCEL) SEC Filing 10-K Annual report for the fiscal year ending Thursday, December 31, 2009

Therapy Cells Inc

CIK: 1429859 Ticker: TCEL

View differences made from one year to another to evaluate Therapy Cells Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Therapy Cells Inc.

Continue

Assess how Therapy Cells Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Therapy Cells Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2010 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Therapy Cells Inc provided additional information to their SEC Filing as exhibits

Ticker: TCEL
CIK: 1429859
Form Type: 10-K Annual Report
Accession Number: 0001092306-10-000208
Submitted to the SEC: Thu Apr 15 2010 4:39:46 PM EST
Accepted by the SEC: Thu Apr 15 2010
Period: Thursday, December 31, 2009
Industry: Wholesale Jewelry Watches Precious Stones And Metals

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/tcel/0001092306-10-000208.htm